Coexpression of TIGIT and FCRL3 Identifies Helios+ Human Memory Regulatory T Cells
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Two distinct subsets of CD4+Foxp3+ regulatory T (Treg) cells have been described based on the differential expression of Helios, a transcription factor of the Ikaros family. Efforts to understand the origin and biological roles of these Treg populations in regulating immune responses have, however, been hindered by the lack of reliable surface markers to distinguish and isolate them for subsequent functional studies. Using a single-cell cloning strategy coupled with microarray analysis of different Treg functional subsets in humans, we identify the mRNA and protein expression of TIGIT and FCRL3 as a novel surface marker combination that distinguishes Helios+FOXP3+ from Helios−FOXP3+ memory cells. Unlike conventional markers that are modulated on conventional T cells upon activation, we show that the TIGIT/FCRL3 combination allows reliable identification of Helios+ Treg cells even in highly activated conditions in vitro as well as in PBMCs of autoimmune patients. We also demonstrate that the Helios−FOXP3+ Treg subpopulation harbors a larger proportion of nonsuppressive clones compared with the Helios+FOXP3+ cell subset, which is highly enriched for suppressive clones. Moreover, we find that Helios− cells are exclusively responsible for the productions of the inflammatory cytokines IFN-γ, IL-2, and IL-17 in FOXP3+ cells ex vivo, highlighting important functional differences between Helios+ and Helios− Treg cells. Thus, we identify novel surface markers for the consistent identification and isolation of Helios+ and Helios− memory Treg cells in health and disease, and we further reveal functional differences between these two populations. These new markers should facilitate further elucidation of the functional roles of Helios-based Treg heterogeneity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“On the other hand, human Tregs that express high levels of Helios have a potent suppressive phenotype and are more stable [367].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [367]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Liu, W., Putnam, A. L., Xu-yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A., Kapranov, P., Gingeras, T. R., de St. Groth, B. F., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060772 · Cited by 2,606 · cited 1×
“expression to identify Treg cells (4).”
FOXP3+ regulatory T cells in the human immune system
Sakaguchi, S., Miyara, M., Costantino, C. M., & Hafler, D. A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2785 · Cited by 2,439 · cited 1×
“absence results in severe multiorgan autoimmunity in humans and mice (1, 2).”
BackgroundYu, X., Harden, K., C Gonzalez, L., Francesco, M., Chiang, E., Irving, B., Tom, I., Ivelja, S., Refino, C. J., Clark, H., et al. (2009) · Nature Immunology · doi:10.1038/ni.1674 · Cited by 1,491 · cited 3×
“TIGIT is an immunoregulatory molecule expressed on memory and activated T cells (13).”
BackgroundInfluentialThornton, A. M., Korty, P. E., Tran, D. Q., Wohlfert, E. A., Murray, P. E., Belkaid, Y., & Shevach, E. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904028 · Cited by 1,382 · cited 2×
“Helios has been recently proposed as a marker to distinguish thymus-derived Treg cells from peripherally induced ones in mice (9).”
BackgroundSelf-citationEpigenetic Control of the foxp3 Locus in Regulatory T Cells
Floess, S., Freyer, J., Siewert, C., Baron, U., Olek, S., Polansky, J., Schlawe, K., Chang, H.-D., Bopp, T., Schmitt, E., et al. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050038 · Cited by 1,270 · cited 2×
“pression and suppressive function (26, 27).”
MethodKoch, M. A., Tucker-Heard, G., Perdue, N. R., Killebrew, J. R., Urdahl, K. B., & Campbell, D. J. (2009) · Nature Immunology · doi:10.1038/ni.1731 · Cited by 1,258 · cited 1×
“Whereas some studies on mouse models suggest that upregulation of inflammatory cytokines such as IL-17 and IFN-g occurs in unstable Treg cells, and precedes loss of FOXP3 and adoption of a Tconv phenotype (37, 38), other studies suggest that some FOXP3 Treg cells acquire a transient ability to produce IFN-g and IL-17…”
ResultCD4 + Regulatory T Cells Control T H 17 Responses in a Stat3-Dependent Manner
Chaudhry, A., Rudra, D., Treuting, P., Samstein, R. M., Liang, Y., Kas, A., & Rudensky, A. Y. (2009) · Science · doi:10.1126/science.1172702 · Cited by 1,000 · cited 1×
“Whereas some studies on mouse models suggest that upregulation of inflammatory cytokines such as IL-17 and IFN-g occurs in unstable Treg cells, and precedes loss of FOXP3 and adoption of a Tconv phenotype (37, 38), other studies suggest that some FOXP3 Treg cells acquire a transient ability to produce IFN-g and IL-17…”
ResultJoller, N., Lozano, E., Burkett, P. R., Patel, B., Xiao, S., Zhu, C., Xia, J., Tan, T. G., Sefik, E., Yajnik, V., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.02.012 · Cited by 955 · cited 2×
“(16) found that TIGIT signaling enhanced Treg-mediated suppression of Th1 and Th17, but not of Th2, responses.”
BackgroundAllan, S. E., Crome, S. Q., Crellin, N. K., Passerini, L., Steiner, T. S., Bacchetta, R., Roncarolo, M. G., & Levings, M. K. (2007) · International Immunology · doi:10.1093/intimm/dxm014 · Cited by 872
Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases
Buckner, J. H. (2010) · Nature Reviews Immunology · doi:10.1038/nri2889 · Cited by 789 · cited 1×
“lished based on several animal models (3), investigations on exact”
Background
Cited by
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Cossarizza, A., Chang, H., Radbruch, A., Acs, A., Adam, D., Adam‐Klages, S., Agace, W. W., Aghaeepour, N., Akdis, M., Allez, M., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201970107 · Cited by 979
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
Wing, J. B., Tanaka, A., & Sakaguchi, S. (2019) · Immunity · doi:10.1016/j.immuni.2019.01.020 · Cited by 726
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
Cossarizza, A., Chang, H., Radbruch, A., Abrignani, S., Addo, R., Akdis, M., Andrä, I., Andreata, F., Annunziato, F., Arranz, E., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202170126 · Cited by 531
Stable inhibitory activity of regulatory T cells requires the transcription factor Helios
Kim, H.-J., Barnitz, R. A., Kreslavsky, T., Brown, F. D., Moffett, H., Lemieux, M. E., Kaygusuz, Y., Meissner, T., Holderried, T. A. W., Chan, S., et al. (2015) · Science · doi:10.1126/science.aad0616 · Cited by 441
Divergent Phenotypes of Human Regulatory T Cells Expressing the Receptors TIGIT and CD226
Fuhrman, C. A., Yeh, W.-I., Seay, H. R., Saikumar Lakshmi, P., Chopra, G., Zhang, L., Perry, D. J., McClymont, S. A., Yadav, M., Lopez, M.-C., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402381 · Cited by 262
“TIGIT has recently been associated with Treg biology through transcriptional profiling of Tregs (8, 21, 26, 27), and has also been characterized as highly demethylated in FOXP3 T cells (28).”
BackgroundThornton, A. M., Lu, J., Korty, P. E., Kim, Y. C., Martens, C., Sun, P. D., & Shevach, E. M. (2019) · European Journal of Immunology · doi:10.1002/eji.201847935 · Cited by 203
Self-citationMultiple Sclerosis and T Lymphocytes: An Entangled Story
Legroux, L., & Arbour, N. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9614-0 · Cited by 196
Beyond CTLA-4 and PD-1, the Generation Z of Negative Checkpoint Regulators
Le Mercier, I., Lines, J. L., & Noelle, R. J. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00418 · Cited by 195
“In human, co-expression of TIGIT and Fc receptor-like protein 3 (FCRL3) identifies Helios + memory Tregs (125, 126).”
BackgroundModulation of regulatory T cell function and stability by co-inhibitory receptors
Lucca, L. E., & Dominguez-Villar, M. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0296-3 · Cited by 189
The Ligands for Human IgG and Their Effector Functions
de Taeye, S. W., Rispens, T., & Vidarsson, G. (2019) · Antibodies · doi:10.3390/antib8020030 · Cited by 170
Peterson, L. B., Bell, C. J. M., Howlett, S., Pękalski, M. Ł., Brady, K., Hinton, H. J., Sauter, D., Todd, J. A., Umaña, P., Ast, O., et al. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.10.017 · Cited by 161
Dawson, N. A. J., Rosado-Sánchez, I., Novakovsky, G. E., Fung, V. C. W., Huang, Q., McIver, E., Sun, G., Gillies, J., Speck, M., Orban, P. C., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz3866 · Cited by 147
HIV persists in CCR6+CD4+ T cells from colon and blood during antiretroviral therapy
Gosselin, A., Wiche Salinas, T. R., Planas, D., Wacleche, V. S., Zhang, Y., Fromentin, R., Chomont, N., Cohen, É. A., Shacklett, B., Mehraj, V., et al. (2017) · AIDS · doi:10.1097/qad.0000000000001309 · Cited by 137
TIGIT+ iTregs elicited by human regulatory macrophages control T cell immunity
Riquelme, P., Haarer, J., Kammler, A., Walter, L. M., Tomiuk, S., Ahrens, N., Wege, A. K., Göcze, I., Zecher, D., Banas, B., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05167-8 · Cited by 131
Yang, Z.-Z., Kim, H. J., Wu, H., Jalali, S., Tang, X., Krull, J. E., Ding, W., Novak, A. J., & Ansell, S. M. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-0558 · Cited by 116
“It has been shown that TIGIT is expressed on Treg cells (34, 35) and we found that Treg cells were the major T-cell subset to express TIGIT in follicular lymphoma.”
BackgroundMechanisms of human FoxP3+ Treg cell development and function in health and disease
Attias, M., Al-Aubodah, T.-A., & Piccirillo, C. A. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13290 · Cited by 114
Self-citationRegulatory T cells and type 2 innate lymphoid cell‐dependent asthma
Aron, J., & Akbari, O. (2017) · Allergy · doi:10.1111/all.13139 · Cited by 103
“Activated conventional CD4 T (Tconv) cells that express Foxp3 can be CD4CD25CD127, so that even if the intracellular localization of Foxp3 in human cells did not prohibit live sorting, these markers are not sufficient, and thus, additional markers are necessary to isolate the suppressive Treg population (61).”
BackgroundMijnheer, G., Lutter, L., Mokrý, M., van der Wal, M., Scholman, R. C., Fleskens, V., Pandit, A., Tao, W., Wekking, M., Vervoort, S. J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22975-7 · Cited by 101
Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP
Elkord, E., Abd Al Samid, M., & Chaudhary, B. (2015) · Oncotarget · doi:10.18632/oncotarget.4771 · Cited by 94
“They have also been reported to comprise a significantly larger proportion of non-suppressive T cell clones compared to FoxP3+Helios+ Tregs [39].”
ResultNegative immune checkpoints on T lymphocytes and their relevance to cancer immunotherapy
Śledzińska, A., Menger, L., Bergerhoff, K. F., Peggs, K. S., & Quezada, S. A. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.10.008 · Cited by 101
Helios is a marker, not a driver, of human Treg stability
Lam, A. J., Uday, P., Gillies, J. K., & Levings, M. K. (2022) · European Journal of Immunology · doi:10.1002/eji.202149318 · Cited by 92
Devi-Marulkar, P., Fastenackels, S., Karapentiantz, P., Goc, J., Germain, C., Kaplon, H., Knockaert, S., Olive, D., Panouillot, M., Validire, P., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-04356-y · Cited by 110
Cells with Treg-specific FOXP3 demethylation but low CD25 are prevalent in autoimmunity
Ferreira, R. C., Simons, H. Z., Thompson, W. S., Rainbow, D. B., Yang, X., Cutler, A. J., Oliveira, J., Castro Dopico, X., Smyth, D. J., Savinykh, N., et al. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.07.009 · Cited by 89
Linc-POU3F3 promotes cell proliferation in gastric cancer via increasing T-reg distribution.
Xiong, G., Yang, L., Chen, Y., & Fan, Z. (2015) · PubMed · Cited by 92
Human FOXP 3+ T regulatory cell heterogeneity
Mohr, A., Malhotra, R., Mayer, G., Gorochov, G., & Miyara, M. (2018) · Clinical & Translational Immunology · doi:10.1002/cti2.1005 · Cited by 99
“Surface markers enabling the isolation of Helios Treg cells in humans have been described, that is, TIGIT and FCRL3.(15) Nevertheless, FCRL3 has also been described as a Treg cell marker for poor proliferative response in the presence of IL-2 and reduced suppressive capacities.”
BackgroundLi, H., Borrego, F., Nagata, S., & Tolnay, M. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501027 · Cited by 81
Self-citationUpdate on Fc receptor-like (FCRL) family: new immunoregulatory players in health and diseases
Rostamzadeh, D., Kazemi, T., Amirghofran, Z., & Shabani, M. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1472768 · Cited by 73
“Another subpopulation of Treg cells called as Helios Treg cell co-expressed FCRL3 and TIGIT (T-cell immunoreceptor with Ig and ITIM domains) [48].”
BackgroundResultInfluentialRegulatory T cells in acute and chronic kidney diseases
Sharma, R., & Kinsey, G. R. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00236.2017 · Cited by 69
Li, P., Liu, C., Yu, Z., & Wu, M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00574 · Cited by 66
“Furthermore, a study of human Treg subsets described an important role for T cell immunoreceptor with Ig and ITIM domains (TIGIT) and FcR-like 3 (FCRL3) in distinguishing tTreg cells from pTreg cells (25).”
BackgroundYang, Y. H., Istomine, R., Alvarez, F., Al-Aubodah, T.-A., Shi, X., Takano, T., Thornton, A. M., Shevach, E. M., Zhang, J., & Piccirillo, C. A. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.002 · Cited by 60
“Finally, we assessed the expression of the transcription factor Helios in these conditions, as it was recently described to identify a lineage of enhanced and stable suppressive Treg cells (Bin Dhuban et al., 2015; Thornton et al., 2019).”
Self-citationSuppression by human FOXP3 + regulatory T cells requires FOXP3-TIP60 interactions
Bin Dhuban, K., d’Hennezel, E., Nagai, Y., Xiao, Y., Shao, S., Istomine, R., Alvarez, F., Ben-Shoshan, M., Ochs, H., Mazer, B., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aai9297 · Cited by 57
Self-citationMinimum Information about T Regulatory Cells: A Step toward Reproducibility and Standardization
Fuchs, A., Gliwiński, M., Grageda, N., Spiering, R., Abbas, A. K., Appel, S., Bacchetta, R., Battaglia, M., Berglund, D., Blazar, B. R., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01844 · Cited by 55
Self-citationPromises and paradoxes of regulatory T cells in inflammatory bowel disease
Lord, J. D. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i40.11236 · Cited by 62
GPA33: A Marker to Identify Stable Human Regulatory T Cells
Opstelten, R., de Kivit, S., Slot, M. C., van den Biggelaar, M., Iwaszkiewicz‐Grześ, D., Gliwiński, M., Scott, A. M., Blom, B., Trzonkowski, P., Borst, J. G., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901250 · Cited by 57
Improving the Efficacy of Regulatory T Cell Therapy
Baeten, P., Zeebroeck, L. V., Kleinewietfeld, M., Hellings, N., & Broux, B. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-021-08866-1 · Cited by 55
“Helios+ Tregs are highly suppressive, while Helios− Tregs exclusively produce inflammatory cytokines [182].”
BackgroundKaufman, G., Massoud, A. H., Dembele, M., Yona, M., Piccirillo, C. A., & Mazer, B. D. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00469 · Cited by 59
“(18) has identified two cell-surface Treg markers: TIGIT, a novel CD28related protein, and FCRL3, an Fc-receptor-like glycoprotein, which allow for high-consistency detection of Treg in human peripheral blood mononuclear cells (PBMCs).”
BackgroundSelf-citationRegulatory T Cell Responses to High-Dose Methylprednisolone in Active Systemic Lupus Erythematosus
Mathian, A., Jouenne, R., Chader, D., Aubart, F. C., Haroche, J., Fadlallah, J., Claër, L., Musset, L., Gorochov, G., Amoura, Z., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143689 · Cited by 55
“However, we did not study other known markers for Tregs such as CD127 [59] and Helios [60, 61] which have already been evaluated in lupus [62–65] or new markers such as TIGIT [66] or FCRL3 [67].”
Inducing and Administering Tregs to Treat Human Disease
Perdigoto, A. L., Chatenoud, L., Bluestone, J. A., & Herold, K. C. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00654 · Cited by 49
“Helios Initially identified as a marker of tTregs, but more recently found on pTregs as well (40, 41, 44)”
BackgroundMotwani, K., Peters, L. D., Vliegen, W. H., Elsayed, A. G., Seay, H. R., López, M. C., Baker, H. V., Posgai, A. L., Brusko, M., Perry, D. J., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00611 · Cited by 55
“In contrast, the clusters that were moderately expanded in CB represent activated, functional Tregs expressing markers conferring adhesive and migratory potential, namely C01 (JUNB, DUSP2, and ITGB1), C02 (IDI1, FCRL3, ID3), and C06.”
BackgroundTIGIT, A Novel Therapeutic Target for Tumor Immunotherapy
Liu, X., Hou, M., & Liu, Y. (2016) · Immunological Investigations · doi:10.1080/08820139.2016.1237524 · Cited by 47
Urbano, P. C. M., Koenen, H. J. P. M., Joosten, I., & He, X. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00573 · Cited by 48
Phenotypic and Functional Diversity in Regulatory T Cells
Sjaastad, L. E., Owen, D. L., Tracy, S. I., & Farrar, M. A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.715901 · Cited by 54
Asemani, Y., Najafi, S., Ezzatifar, F., Zolbanin, N. M., & Jafari, R. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00808-4 · Cited by 47
Yang, M., Liu, Y., Mo, B., Xue, Y., Ye, C., Jiang, Y., Bi, X., Liu, M., Wu, Y., Wang, J., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.2139/ssrn.3228224 · Cited by 43
Mahnke, K., & Enk, A. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2015.10.048 · Cited by 41
Kumar, K. P., Ooi, J. D., & Goldberg, R. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1291724 · Cited by 46
Han, J., Cai, M., Grein, J., Perera, S. A., Wang, H., Bigler, M., Ueda, R., Rosahl, T. W., Pinheiro, E. M., LaFace, D., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.573405 · Cited by 40
“Because TIGIT is highly expressed on a subpopulation of Tregs that express Helios (16, 17), we hypothesized that an anti-TIGIT:mIgG2a may also deplete intratumoral Tregs that co-express TIGIT and Helios.”
BackgroundInfluentialCochrane, R. W., Robino, R. A., Granger, B., Allen, E., Vaena, S. G., Romeo, M. J., de Cubas, A. A., Berto, S., & Ferreira, L. M. R. (2024) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2024.101385 · Cited by 44
Seng, A., Krausz, K. L., Pei, D., Koestler, D. C., Fischer, R. T., Yankee, T. M., & Markiewicz, M. A. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019000965 · Cited by 42
Wen, X., Yang, J., James, E., Chow, I.-T., Reijonen, H., & Kwok, W. W. (2020) · Science Immunology · doi:10.1126/sciimmunol.aax8767 · Cited by 35
Andersson, K., Cavallini, N. F., Hu, D., Brisslert, M., Cialic, R., Valadi, H., Erlandsson, M. C., Silfverswärd, S. T., Pullerits, R., Kuchroo, V. K., et al. (2015) · Molecular Medicine · doi:10.2119/molmed.2015.00057 · Cited by 33
Abdeladhim, M., Karnell, J. L., & Rieder, S. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1033705 · Cited by 40
Self-citationTreg in inborn errors of immunity: gaps, knowns and future perspectives
Kennedy-Batalla, R., Acevedo, D., Luo, Y., Esteve‐Solé, A., Vlagea, A. D., Correa‐Rocha, R., Seoane-Reula, E., & Alsina, L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1278759 · Cited by 39
Divergent LAG-3 versus BTLA, TIGIT, and FCRL3 expression in Sézary syndrome
Anzengruber, F., Ignatova, D., Schlaepfer, T., Chang, Y., French, L. E., Pascolo, S., Contassot, E., Bobrowicz, M., Hoetzenecker, W., & Guenova, E. (2019) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2018.1564827 · Cited by 32
“immune responses and autoimmune diseases [38].”
One, No One, and One Hundred Thousand: T Regulatory Cells' Multiple Identities in Neuroimmunity
Sambucci, M., Gargano, F., Guerrera, G., Battistini, L., & Borsellino, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02947 · Cited by 32
“The effector and naïve phenotypes are associated with differential expression of other molecules, such as CD39, CCR6, HLA-DR, GITR, LAG3 (60, 61), which are involved in the suppressive function and migratory ability of Tregs, and which may be expressed at different times during the cells’ life.”
BackgroundInfluentialTranscriptional regulation of Treg homeostasis and functional specification
Wang, K., & Fu, W. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03534-7 · Cited by 37
Noyan, K., Nguyen, S., Betts, M. R., Sönnerborg, A. B., & Buggert, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00019 · Cited by 30
TIGIT and Helios Are Highly Expressed on CD4+ T Cells in Sézary Syndrome Patients
Jariwala, N. N., Benoit, B. M., Kossenkov, A. V., Oetjen, L. K., Whelan, T. M., Cornejo, C. M., Takeshita, J., Kim, B., Showe, L. C., Wysocka, M., et al. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.08.016 · Cited by 26
“A recent report linked the expression of FCRL3 with the expression of TIGIT and Helios (Bin Dhuban et al., 2015).”
BackgroundSignaling Through gp130 Compromises Suppressive Function in Human FOXP3+ Regulatory T Cells
Dhuban, K. B., Bartolucci, S., d'Hennezel, E. B., & Piccirillo, C. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01532 · Cited by 27
“Using a single-cell cloning strategy that allows the discrimination between activated Teff contaminants and bona fide FOXP3-expressing Treg clones, we have recently shown that the human FOXP3 Treg population is functionally heterogeneous, containing a sizeable proportion of clones with an impaired capacity to suppress…”
InfluentialSelf-citationSøndergaard, J. N., Tulyeu, J., Edahiro, R., Shirai, Y., Yamaguchi, Y., Murakami, T., Morita, T., Kato, Y., Hirata, H., Takeda, Y., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2217902120 · Cited by 25
Role of heterogeneous regulatory T cells in the tumor microenvironment
Wei, T., Zhong, W., & Li, Q. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104659 · Cited by 28
Brown, C. Y., Sadlon, T. J., Hope, C. M., Wong, Y. Y., Wong, S. W., Liu, N., Withers, H., Brown, K., Bandara, V., Gundsambuu, B., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01269 · Cited by 26
“The mechanism for TIGIT in establishing the suppressor function both directly and indirectly includes induction of tolerogenic dendritic cells (14, 15), and coexpression with FcRL3 marks human memory Treg that express Helios and are highly suppressive (17).”
BackgroundLiu, J., Wang, X., Deng, Y., Yu, X., Wang, H., & Li, Z. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.766248 · Cited by 27
“Besides Helios, other markers, like TIGIT, CD226 (128), CD15s, HLADR, TIM-3, CD177 (47), and ICOS (131, 132), are promising markers expressed by Tregs that have the potential to further classify Tregs based on their function.”
BackgroundCo-Expression of TIGIT and Helios Marks Immunosenescent CD8+ T Cells During Aging
Pieren, D. K. J., Smits, N. A. M., Postel, R. J., Kandiah, V., de Wit, J., van Beek, J., van Baarle, D., & Guichelaar, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.833531 · Cited by 23
“For example, Helios co-expression with TIGIT has been described in CD4 T cells to define a functionally distinct cell subset that is characterized by regulatory properties (18, 19).”
BackgroundDao, A. T. T., Yamazaki, H., Takamatsu, H., Sugimori, C., Katagiri, T., Maruyama, H., Zaimoku, Y., Maruyama, K., Ly, Q. T., Espinoza, L., et al. (2016) · Annals of Hematology · doi:10.1007/s00277-016-2629-7 · Cited by 22
“These results were in agreement with a previous study which found that the Helios Treg subpopulation harbors a larger population of non-suppressive clones than the Helios cell subset [17].”
ResultMohr, A., Trésallet, C., Monot, N., Bauvois, A., Abiven, D., Atif, M., Claër, L., Malhotra, R., Mayer, G., BALDERAS, R. S., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00601 · Cited by 24
“precisely differentiated by surface markers such as those utilized in this study and by others (4, 26, 27).”
MethodFerreira, R. C., Rainbow, D. B., Rubio García, A., Pekalski, M. L., Porter, L., Oliveira, J. J., Waldron-Lynch, F., Wicker, L. S., & Todd, J. A. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.03.002 · Cited by 19
Alvarez, F., Istomine, R., Filho, A. D. S. L., Al-Aubodah, T.-A., Huang, D. Q., Okde, R., Olivier, M., Fritz, J. H., & Piccirillo, C. A. (2023) · Mucosal Immunology · doi:10.1016/j.mucimm.2023.05.004 · Cited by 25
Self-citationRamos‐Ramírez, P., Malmhäll, C., Johansson, K., Lötvall, J. O., & Bossios, A. (2016) · Scandinavian Journal of Immunology · doi:10.1111/sji.12419 · Cited by 19
Untangling the Knots of Regulatory T Cell Therapy in Solid Organ Transplantation
Orozco, G., Gupta, M., Gedaly, R., & Martí, F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.883855 · Cited by 21
“immunoreceptor with Ig and ITIM domains (TIGIT) and Fc Receptor-like 3 (FCRL3, CD307c) in Helios FoxP3 Treg cells (29) could facilitate reliable identification and selection of Helios Treg cells.”
BackgroundPhenotype and function of tissue-resident unconventional Foxp3-expressing CD4+ regulatory T cells
Lü, J., Meng, H., Zhang, A., Yang, J., & Zhang, X. (2015) · Cellular Immunology · doi:10.1016/j.cellimm.2015.06.005 · Cited by 19
Sun, Y., Anyalebechi, J. C., Sun, H. Y., Yumoto, T., Xue, M., Liu, D., Liang, Z., Coopersmith, C. M., & Ford, M. L. (2021) · JCI Insight · doi:10.1172/jci.insight.141245 · Cited by 17
“Tregs from peripherally induced ones and is also indicative of more stable and functional Tregs (35).”
BackgroundBattella, S., Oliva, S., Franchitti, L., Scaleia, R. L., Soriani, A., Isoldi, S., Capuano, C., Pighi, C., Morrone, S., Galandrini, R., et al. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0208-7 · Cited by 15
Shukri, N. D. M., Izati, A. F., Ghazali, W. S. W., Hussin, C. M. C., & Wong, K. K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.675250 · Cited by 12
“CD3, CD4, gp130 and IL-12Rb2) to define the T cell subsets without including markers to identify Tregs and Bregs that produce IL-35, as well as their subpopulations particularly Tregs without functional suppressive capacity typically characterized by FOXP3Helios expression (29, 58, 65); 2) We did not include a viabili…”
BackgroundTherapeutic application of T regulatory cells in composite tissue allotransplantation
Yang, J.-H., & Eun, S. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1322-5 · Cited by 16
“Among population of Helios+Foxp3+ Treg cells enriched for suppressive clones, Helios−Foxp3+ Treg subpopulation is found to harbor nonsuppressive clones with production of proinflammatory cytokines such as IFN-r, IL-2, and IL-17 [70].”
BackgroundZhang, Y., Li, L., Genest, G., Zhao, W., Ke, D., Bartolucci, S., Pavey, N., Al-Aubodah, T.-A., Lejtenyi, D., Torabi, B., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.705615 · Cited by 13
“Most commonly used TREG markers are also inducible on effector T cells (TEFF) upon TCR-mediated activation, blurring the distinction between human TREG and activated TEFF cells, increasing the functional heterogeneity of the population and confounding the interpretation of results (25).”
BackgroundSelf-citationAge‐ and sex‐mediated differences in T lymphocyte populations of kidney transplant recipients
Dziarmaga, R., Ke, D., Sapir‐Pichhadze, R., Cardinal, H., Phan, V., Piccirillo, C. A., Mazer, B. D., & Foster, B. J. (2021) · Pediatric Transplantation · doi:10.1111/petr.14150 · Cited by 12
Self-citationStabilizing Human Regulatory T Cells for Tolerance Inducing Immunotherapy
He, X., Koenen, H. J. P. M., Slaats, J., & Joosten, I. (2017) · Immunotherapy · doi:10.2217/imt-2017-0017 · Cited by 13
Štefanić, M., Tokić, S., Suver-Stević, M., & Glavaš‐Obrovac, L. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0597-8948 · Cited by 13
Watanabe, M., Kumagai‐Braesch, M., Yao, M. H., Thunberg, S., Berglund, D., Sellberg, F., Jorns, C., Enoksson, S. L., Henriksson, J., Lundgren, T., et al. (2018) · Cell Transplantation · doi:10.1177/0963689718794642 · Cited by 11
Moerman, A., Mehdi, S. J., & Wong, H. K. (2020) · Cells · doi:10.3390/cells9091992 · Cited by 11
“While it is well known that SS malignant T cells express Th2 cytokines, they also variably express characteristics of regulatory T cells (Tregs), including expression of forkhead box P3 (FoxP3), inhibitory receptors, and immunoregulatory cytokines [81,122].”
BackgroundInfluentialYousefi, Z., Sharifzadeh, S., Yar-Ahmadi, V., Andalib, A., & Eskandari, N. (2019) · Biomarker Insights · doi:10.1177/1177271919882351 · Cited by 13
Sun, Y., Xie, J., Anyalebechi, J. C., Chen, C., Sun, H. Y., Xue, M., Liang, Z., Morrow, K. N., Coopersmith, C. M., & Ford, M. L. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000595 · Cited by 10
Bahabayi, A., Zhang, Y., Yuan, Z., Wang, Y., Zhang, Z., Zeng, X., Guan, Z., Wang, P., & Liu, C. (2024) · European Journal of Immunology · doi:10.1002/eji.202350739 · Cited by 9
Manuszak, C., Brainard, M., Thrash, E. M., Hodi, F. S., & Severgnini, M. (2020) · Journal of Biological Methods · doi:10.14440/jbm.2020.325 · Cited by 9
“This rare and fatal syndrome functions in the development of autoimmune diseases, such as type 1 diabetes and dermatitis [2,4].”
BackgroundLi, S., Zhang, P., Li, A., Bao, J., Pan, Z., & Jie, Y. (2022) · Transplantation · doi:10.1097/tp.0000000000004257 · Cited by 9
“According to Bin Dhuban et al, TIGIT could effectively distinguish HeliosFoxp3 from HeliosFoxp3 Treg.(29) These findings are in support of our results.”
ResultYousefi, Z., & Eskandari, N. (2019) · Leukemia Research Reports · doi:10.1016/j.lrr.2019.100181 · Cited by 8
The Role of the Ikaros Family of Transcription Factors in Regulatory T cell Development and Function
Seng, A., & Yankee, T. M. (2017) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000495 · Cited by 10
“Besides differences in functionality between Helios+ and HeliosTreg cells, Helios+ Treg cells are more stable under inflammatory conditions than Helios- Treg cells [14,33,43,44].”
BackgroundSantagata, S., Trotta, A. M., D’Alterio, C., Napolitano, M., Rea, G., Napoli, M. D., Portella, L., Ieranò, C., Guardascione, G., Coppola, E., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-0729 · Cited by 7
“The meaning of Helios+ Treg cells is not entirely clear, with conflicting results that are dependent on context and Treg evaluation as distinct functional subpopulations (57, 58), FOXP3 stability (59), epigenetic changes (60, 61), and function as CFSE assay proliferation (62, 63).”
CD8 + T regulatory cells in lupus
Singh, R. P., Bischoff, D. S., & Hahn, B. H. (2021) · Rheumatology and Immunology Research · doi:10.2478/rir-2021-0021 · Cited by 11
Xu, Z., Li, R., Wang, L., Wu, Y., Tian, Y., Su, Y., Ma, Y., Li, R., Wei, Y., Zhang, C., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1349470 · Cited by 10
Sérazin, C., Dugast, L., Flippe, L., Streitz, M., Wendering, D. J., Schlickeiser, S., Heinrich, F., Durek, P., Guerra, G. M., Lehmann, K., et al. (2025) · iScience · doi:10.1016/j.isci.2025.113512 · Cited by 7
Zhuang, Q., Cai, H., Yang, M., Peng, B., Luo, Y., Zhang, Y., & Ming, Y. (2022) · Journal of Immunology Research · doi:10.1155/2022/8720438 · Cited by 6
“Compared with Helios Tregs, Helios Tregs have a reduced suppressive capacity and secrete inflammatory factors [43].”
Human small intestine contains 2 functionally distinct regulatory T-cell subsets
Chauhan, S. K., Bartolomé-Casado, R., Landsverk, O. J. B., Johannessen, H., Phung, D., Nilsen, H. R., Sætre, F., Jahnsen, J., Horneland, R., Yaqub, S., et al. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.02.030 · Cited by 9
Fc receptor-like proteins and their role in B-cell responses and autoimmune diseases
Haroun, C., Kroese, F. G. M., & Verstappen, G. M. P. J. (2026) · Immunology Letters · doi:10.1016/j.imlet.2026.107144 · Cited by 4
Non-coding RNA in tumor-infiltrating regulatory T cells formation and associated immunotherapy
Ma, Y., Xu, X., Wang, H., Liu, Y., & Piao, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1228331 · Cited by 10
Takahashi, H., Tsuboi, H., Abe, S., Honda, F., Kondo, Y., Matsumoto, I., & Sumida, T. (2021) · Clinical & Experimental Immunology · doi:10.1111/cei.13583 · Cited by 4
Immune Regulation in Human Health and Disease
Bartolucci, S., & Piccirillo, C. A. (2017) · Wiley eBooks · doi:10.1002/9780470015902.a0000952.pub2 · Cited by 6
Self-citationTrang, B. K., Sharma, P. K., Cook, L. E., Mount, Z., Thomas, R. M., Kulkarni, N. N., Cabrera, E. C., Rachimi, S., Pahl, M. C., Pippin, J. A., et al. (2025) · Genome biology · doi:10.1186/s13059-025-03880-4 · Cited by 10
FCRL3 is an immunoregulatory receptor that restrains the activation of human memory T lymphocytes
Bianchi, N., Foli, E., Mostanfar, M., Marzi, R., Spinella, M. C., Polletti, S., Pecoraro, M., Cassotta, A., Thakur, R. S., Jarrossay, D., et al. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20242474 · Cited by 4
“Among T lymphocytes, FCRL3 is highly expressed by a subset of Treg cells (Bin Dhuban et al., 2015; Nagata et al., 2009; Swainson et al., 2010), where it was shown to modulate cytokine production and to limit suppressive capacity (Agarwal et al., 2020).”
Metadata
- Authors
- Bin Dhuban, K., d’Hennezel, E., Nashi, E., Bar-Or, A., Rieder, S., Shevach, E. M., Nagata, S., & Piccirillo, C. A.
- Affiliations
- Department of Microbiology and Immunology, McGill University , Montreal, Quebec H3G 1A4 ,
- McGill University Health Centre (CA)
- Neuroimmunology Unit, Montreal Neurological Institute and Hospital, McGill University , Montreal, Quebec H3A 2B4 ,
- National Institutes of Health (US)
- Sanford Research (US)
- Research Institute of the McGill University Health Centre (CA)
- Corresponding author
- Piccirillo, Ciriaco A
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-04
- Volume
- 194
- Issue
- 8
- Pages
- 3687-3696
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC4610024
- OpenAlex
- W2147953838
- Cited by
- 117
- References
- 42
- Citations by year
- 2026: 2 · 2025: 10 · 2024: 6 · 2023: 5 · 2022: 8 · 2021: 14 · 2020: 18 · 2019: 12 · 2018: 10 · 2017: 9 · 2016: 10 · 2015: 13
- FWCI
- 6.89
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- McGill University
- McGill University Health Centre
- National Institutes of Health (GM103548)
- Canadian Institutes of Health Research (MOP84041, MOP67211)
- National Institute of General Medical Sciences (P20GM103548)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Keywords
- Helios, TIGIT, FCRL3, regulatory T cells, Foxp3, cell surface markers, Treg heterogeneity, suppressive function, interferon-gamma, IL-17, interleukin-2, autoimmune disease, Treg isolation
- MeSH terms
- Autoimmune Diseases, Female, Gene Expression Regulation, Humans, Immunologic Memory, Male, Receptors, Immunologic, Biomarkers, Cytokines, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, T-Lymphocytes, Regulatory, Ikaros Transcription Factor, Forkhead Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.